Low frequency of CD3+CD4+CD161+ T cells correlates with the occurrence of infections in refractory/relapsed multiple myeloma patients receiving lenalidomide plus low-dose dexamethasone treatment-Reference-Cited by-同舟云学术

Low frequency of CD3+CD4+CD161+ T cells correlates with the occurrence of infections in refractory/relapsed multiple myeloma patients receiving lenalidomide plus low-dose dexamethasone treatment

Published:2018-06-25 Issue:11 Volume:97 Page:2163-2171
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Lee Sung-Eun,Lim Ji-Young,Ryu Da-Bin,Kim Tae Woo,Park Sung Soo,Jeon Young-Woo,Yoon Jae-Ho,Cho Byung-Sik,Eom Ki-Seong,Kim Yoo-Jin,Kim Hee-Je,Lee Seok,Cho Seok-Goo,Kim Dong-Wook,Lee Jong Wook,Min Chang-Ki

Funder

The Ministry of Health & Welfare, Republic of Korea

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/article/10.1007/s00277-018-3401-y/fulltext.html

Reference36 articles.

1. Palumbo A, Anderson K (2011) Multiple myeloma. N Engl J Med 364:1046–1060

2. Augustson BM, Begum G, Dunn JA, Barth NJ, Davies F, Morgan G, Behrens J, Smith A, Child JA, Drayson MT (2005) Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United Kingdom Medical Research Council trials between 1980 and 2002—Medical Research Council Adult Leukaemia Working Party. J Clin Oncol 23:9219–9226

3. Blimark C, Holmberg E, Mellqvist UH, Landgren O, Bjorkholm M, Hultcrantz M, Kjellander C, Turesson I, Kristinsson SY (2015) Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients. Haematologica 100:107–113